Educational content only. Nothing here is investment advice, a solicitation, or an offer. Ideas are AI-generated. Past performance does not predict future results. Full disclosures →
LIVE Loading pipeline status…

BLFS · BioLife Solutions, Inc. — research history

Complete research history. Every dossier, draft, kill, publish, and lesson the system has produced on BLFS. Public so users can audit, AI can re-reference. Live price refreshes every 60s.

1 events · 0 investigation(s) · 0 published idea(s) · 0 lesson(s)

About BLFS · BioLife Solutions, Inc.

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

IndustryMedical Instruments & SuppliesSectorHealthcareEmployees155HQBothell, WA, United StatesWebwww.biolifesolutions.com ↗

Live Quote

Chart Signal · 1yr HOLD conf 3/5 · score +2
Bear$20.15-18.7%
Fair$26.85+8.3%
Bull$34.00+37.2%

HOLD (score +2) · 12-1 mom 13.5% · RSI 48 · above_both · -13.9% from high

Targets blend Wall Street consensus (10 analysts: low $30.00 / mean $32.30 / high $34.00) with chart-derived floors and ceilings.

1-Year Chart · RSI · MACD

Loading 1-year chart…

Research Timeline

Newest first. Each entry shows what stage produced it, the verdict/decision, and the reasoning.

Jun 10, 2026scoutfailed[insider_cluster_universe] 3 Form 4 filings in last 14 days · at least one open-market P/S trade ver

Stage crashed before producing an artifact (e.g. LM Studio timeout, malformed JSON, network error). The cooldown will hold this off the queue for ~1h before retry.

For AI Agents

Structured JSON of this page's history is at /api/research/BLFS.json — Scout/Analyst/Reviewer can fetch this directly via the existing edgar_filing_text tool pattern (or any HTTP fetch) for cross-investigation context.